Tuberous sclerosis complex (TSC) is an autosomal dominantly inherited disease with a high mutation rate.
according to the criteria of Gomez ( The proband's father was evaluated at 30 years of age. CT scan of the brain, echography of the heart, and investigation of the skin (Woods light) and retina were normal. Echography of the kidney showed slightly increased echodensity with unilateral multiple echodensities 1 mm in diameter, located either in the capsula or in the peripheral cortex. These echodensities were non-specific, unlike renal angiomyolipoma, the characteristic renal lesion in TSC, which is generally located in the parenchyma in combination with renal cysts. On all tooth surfaces pit shaped enamel defects were seen, corresponding to the dental pits described in patients with tuberous sclerosis. '8 In addition two gingival fibromas were found (fig 2) . Thus, the father shows two "suspect" oral symptoms (table) .
In summary, from the combination of signs in the father and son it is very likely that they both have TSC. All first degree relatives of the father and son were screened for signs of tuberous sclerosis, but no abnormalities were detected on full clinical evaluation.
Methods CLINICAL EXAMINATION
All first degree relatives of III-1 and II-3 were screened for signs of tuberous sclerosis. Physical examination, dermatological examination with Woods lamp, a CT scan of the brain, x rays of both hands and feet, and echographical examination of the heart and kidneys were performed in all family members, including the father of the proband, and were normal.
MUTATION ANALYSIS
In principle all patients included in the mutation analysis fulfilled the diagnostic criteria of Gomez, 19 unless 
Sequence analysis
For sequencing of PCR products, 100 jl of PCR product was purified and concentrated on microcon 30 (Amicon). The double stranded DNA cycle sequencing system (Gibco/BRL) was used to sequence PCR fragments directly: six minutes at 94°C followed by 30 cycles of 30 seconds at 94°C, 30 seconds at 55°C, 60 seconds at 720C, and six minutes at 720C in the last cycle. Sequencing of both strands was performed with the primers used for the SSCP analysis.
ASO hybridisation For the ASO hybridisation the sequence of the "normal" oligonucleotide was 5'-CTTGAAG-GAGAAGTTTA-3' and for the "mutant" oligonucleotide 5'-CTTGTAGGAGAAGTTT-A-3'. Hybridisation was performed at 37 5°C for 30 minutes. Filters were washed to 0-3 SSC for 10 minutes at 37 50C.
Marker analysis
Markers 3'HVR, KG8, and 1 6AC2.5 (D16S291) were analysed according to standard procedures. 22 Results Mutation analysis of the TSC2 gene in TSC patients has been performed using pulsed field gel electrophoresis (PFGE) and Southern blot- ting analysis, resulting in the detection of a number of large deletions.4"2"4 However, the majority of the TSC2 gene defects are expected to be small mutations. To facilitate the detection of such mutations, the genomic organisation of the TSC2 gene was determined (Maheshwar et al, manuscript submitted) and exon specific primers were designed for single strand confirmation polymorphism (SSCP) analysis. DNA from 116 unrelated TSC patients was analysed to detect mutations in the first exon (nucleotides 1-156 of the published TSC2 cDNA sequence).'2 In one case an additional band was observed. Subsequent sequencing showed an A--T transition at nucleotide position 52, resulting in a change of lysine (AAG) to a stop codon (TAG) at amino acid position 12 (K12X). Allele specific oligonucleotide hybridisation (ASO) was performed on DNA from all family members (fig 3) . The K12X mutation was also present in the proband's father. The other family members, including the twin sisters of the father and their parents, were homozygous for the normal allele. To trace the origin of the mutated allele, linkage analysis with the VNTR probe 3'HVR, located distally to the TSC2 gene, and polymorphic CA repeat markers KG8 and 16AC2.5 (D 1 6S29 1) was undertaken. KG8, the closest marker just proximal to the TSC2 gene, was not informative. 16AC2.5 is positioned about 200 kb proximal to the TSC2 gene.23 Both informative flanking markers proved the mutated chromosome to be of grandmaternal origin. Both twin sisters had received the other grandmaternal chromosome 16 (data not shown).
Discussion
Tuberous sclerosis is a clinically and genetically heterogeneous disease. Half of the patients are expected to have a mutation in the TSC2 gene. From our file of 119 patients, three patients had large deletions in the gene.'2 14 On the hypothesis of an equal distribution ofmutations across the TSC2 gene, which contains 41 exons (Maheshwar et al, manuscript submitted), one or two mutations per exon per 100 patients may be expected. SSCP analysis of the first exon of the TSC2 gene resulted in the identification of the first point mutation. No other mutations were detected in the first exon.
The mutation was found only in the father and in the son. Analysis with flanking polymorphic markers showed that the mutated allele is of grandmaternal origin. After complete clinical examination, the grandmother showed no signs of tuberous sclerosis. Germline mosaicism in the grandmother or a de novo mutation in the father in the early stages of postzygotic cell division has occurred, since the mutation could not be identified in DNA from leucocytes of the grandmother. The possibility of germline mosaicism in the grandmother prompted the analysis of the father's sisters, who were shown to be unaffected, both by mutation analysis and by marker analysis. Recently, we described a case of somatic mosaicism in TSC, based on the identification of a familial mutation.'4 From our analysis there is no suggestion that the father is a somatic mosaic for the mutation although the possibility of a very high grade (>90%) mosaicism cannot be excluded on the basis of the ASO result ( fig  3) . The father showed signs that make him a presumptive tuberous sclerosis patient if the diagnosis is certain in the child, given the criterion of the affected first degree relative.'9 The detection ofthe mutation allowed the suspected affected status in the father to be confirmed, thus making an important contribution to the diagnosis of familial TSC and genetic counselling in this family.
The Kl 2X mutation leads to a truncated peptide of 11 
